Mission Bay Capital logo

Mission Bay Capital

North America, California, United States, San Francisco

Description

Mission Bay Capital is a venture capital firm for early-stage investments.

Investor Profile

Mission Bay Capital has made 36 investments, with 0 in the past 12 months and 6% as lead.

Stage Focus

  • Series B (36%)
  • Series A (28%)
  • Series Unknown (11%)
  • Seed (11%)
  • Series E (3%)
  • Series D (3%)
  • Pre Seed (3%)
  • Angel (3%)
  • Series C (3%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Genetics
  • Pharmaceutical
  • Oncology
  • Medical Device
  • Food And Beverage
  • Food Processing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Mission Bay Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 6
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 3
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Dementia Discovery Fund
Europe, England, United Kingdom, London
Co-Investments: 5
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 5
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 4
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 5
Mission BioCapital
North America, Massachusetts, United States, Cambridge
Co-Investments: 7

Which angels does Mission Bay Capital often collaborate with?

SH
North America, North Carolina, United States, Raleigh
Shared Deals: 1
AB
North America, California, United States, San Francisco
Shared Deals: 1
JR
North America, California, United States, San Francisco
Shared Deals: 1
David Beyer
North America, California, United States, San Francisco
Shared Deals: 1
JD
North America, California, United States, San Francisco
Shared Deals: 1
JR
North America, California, United States, San Francisco
Shared Deals: 1
MB
Europe, Cambridgeshire, United Kingdom, Cambridge
Shared Deals: 1
JF
North America, California, United States
Shared Deals: 1
Shared Deals: 1
Shu Duan
Asia, Hong Kong Island, Hong Kong, Hong Kong
Shared Deals: 1

What are some of recent deals done by Mission Bay Capital?

QurAlis

Cambridge, Massachusetts, United States

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

BiotechnologyGeneticsHealth CarePrecision MedicineTherapeutics
Series BMar 9, 2023
Amount Raised: $88,000,000
Nitrase Therapeutics

Jackson, Mississippi, United States

Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).

BiotechnologyHealth CareTherapeutics
Series ANov 2, 2021
Amount Raised: $7,000,000
Nobell Foods

San Francisco, California, United States

Nobell Foods uses plants to create innovative animal-based food substitutes.

Food and BeverageFood ProcessingNutrition
Series BJul 22, 2021
Amount Raised: $75,000,000
Symbiome

San Francisco, California, United States

Symbiome offers skincare as nature intended solution which is scientifically and intentionally formulated using ancestral ingredients.

Health CareNatural ResourcesWellness
Series UnknownSep 14, 2020
Amount Raised: $15,000,000
Nitrase Therapeutics

Jackson, Mississippi, United States

Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).

BiotechnologyHealth CareTherapeutics
Series AApr 22, 2020
Amount Raised: $38,000,000
Glycomine

San Francisco, California, United States

Glycomine is an early-stage biotech working on replacement therapies for rare diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BAug 7, 2019
Amount Raised: $33,000,000
Alector

San Francisco, California, United States

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.

BiotechnologyGeneticsHealth CareTherapeutics
Series EJul 25, 2018
Amount Raised: $133,000,000
Wildtype

San Francisco, California, United States

Wildtype is a cellular agriculture company that develops technology for cultivating seafood.

AgTechBiotechnologyFood and BeverageFood ProcessingSeafood
SeedMar 30, 2018
Amount Raised: $3,500,000
ViewPoint Therapeutics

San Francisco, California, United States

ViewPoint Therapeutics is a developer of crystallin stabilizers intended to prevent and treat cataracts and presbyopia.

BiotechnologyHealth CareMedicalTherapeutics
Series BMar 5, 2018
Amount Raised: $35,000,000
Pionyr Immunotherapeutics

South San Francisco, California, United States

Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.

BiotechnologyMedicalPharmaceuticalTherapeutics
Series BDec 13, 2017
Amount Raised: $62,000,000